ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 97 locations in 38 countries and has approximately 13,100 employees.
Cytel is helping to shape the future of drug development. As the world’s largest Biometrics CRO we improve our customers’ chances of development success through expert trial design and planning, efficient operational implementation and accurate data analysis. Cytel’s software for the design, analysis and execution of clinical trials is used by all leading pharmaceutical, biotech and medical devices companies. Quality comes first and our objective is to get it right- first time.
Medidata is reinventing global drug development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 850 global pharmaceutical companies, biotech, diagnostic and device firms, academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® is the primary technology platform powering clinical trials for 17 of the world's top 25 pharmaceutical companies, and is used by 16 of the top 20 medical device developers—from study design and planning through execution, management and reporting.
Oracle Health Sciences provides the only eClinical platform made up of best-of-breed solutions powered by the #1 data and cloud technology in the world. With Oracle Heath Sciences, Life Sciences organizations can manage and unify all elements of the Clinical Development Lifecycle in a safe, secure and compliant manner, while also being open, collaborative and adaptive to change.
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.
MassBio's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives.
May 30-31 2018 | Raleigh Convention Center, Raleigh, NC
T3 brings together leading experts, influencers and innovators from across the clinical landscape to provide you with the latest updates and guidance to help you transform your clinical trials.
Join us in Raleigh, North Carolina on May 30-31st for the ultimate opportunity to ask your questions, voice your concerns, connect with peers, discuss new challenges, and get direct feedback from an expert speaker line-up.
We have 4 conference tracks to help you drive success through clinical trials, tech and transformation:
• Paradigm Shifts in Clinical Trials: Partnerships and Collaboration, Digital Transformation, New Technology and Innovation, and The Changing Landscape
• Patients as Partners: Voice of the Patient, Recruitment and Engagement
• Clinical Research: Technology, Real-Time Data and Analytics
• Insights and Innovations from Immuno-oncology and Rare Disease
Download the agenda to see what we have lined up for you. Or visit the website to find out more: www.t3clinicalevent.com